MedTrace Logo

Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)

NCT00181285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2018-08-08

Study results available
· View outcomes & findings →

Summary

The objective of this study was to evaluate the use of high frequency chest wall oscillation (HFCWO) early in the treatment of adults hospitalized for acute asthma or chronic obstructive pulmonary disease (COPD).

Conditions

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Undifferentiated Asthma/COPD

Interventions

DEVICE

High Frequency Chest Wall Oscillator

High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax

Sponsors & Collaborators

  • Hill-Rom

    collaborator INDUSTRY

  • University of Chicago

    lead OTHER

Principal Investigators

  • Jerry A Krishnan, MD, PhD · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00181285 on ClinicalTrials.gov